首页> 外文期刊>The journal of clinical endocrinology and metabolism >Efficacy of Dosimetric Versus Empiric Prescribed Activity of 131I for Therapy of Differentiated Thyroid Cancer
【24h】

Efficacy of Dosimetric Versus Empiric Prescribed Activity of 131I for Therapy of Differentiated Thyroid Cancer

机译:131I剂量对经验性处方药对分化型甲状腺癌的疗效

获取原文
       

摘要

Background:The optimal management of high-risk patients with differentiated thyroid cancer (DTC) consists of thyroidectomy followed by radioiodine (~(131)I) therapy. The prescribed activity of ~(131)I can be determined using two approaches: 1) empiric prescribed activity of ~(131)I (E-Rx); and 2) dosimetry-based prescribed activity of ~(131)I (D-Rx).
机译:背景:对高风险的分化型甲状腺癌(DTC)患者的最佳治疗包括甲状腺切除术然后进行放射性碘(〜(131)I)治疗。 〜(131)I的规定活性可以使用两种方法确定:1)〜(131)I的经验性规定活性(E-Rx); 2)基于剂量法的〜(131)I(D-Rx)处方药活性。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号